ARTICLE | Company News
Apath, Nucleonics deal
November 22, 2004 8:00 AM UTC
Apath granted Nucleonics a non-exclusive license to technology related to the 3' non-translated region of the hepatitis C viral (HCV) genome. Nucleonics will use it as a target for developing an expre...